User profiles for D. Nazareth

Derek Nazareth

- Verified email at uwm.edu - Cited by 1760

Dilip Nazareth

- Verified email at doctors.org.uk - Cited by 847

[HTML][HTML] A review of renal disease in cystic fibrosis

D Nazareth, M Walshaw - Journal of Cystic Fibrosis, 2013 - Elsevier
Kidney disease is becoming increasingly common in CF. This review looks at the effect of
CFTR on the kidney, the problems with measuring renal function effectively in CF, the causes …

A system dynamics model for information security management

DL Nazareth, J Choi - Information & management, 2015 - Elsevier
Managing security for information assets is a critically important and challenging task. As
organizations provide clients with ubiquitous access to information systems and the frequency …

[HTML][HTML] The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

…, A Maitra, G Mujtaba, E Nash, D Nazareth… - Journal of cystic …, 2020 - Elsevier
With the growing SARS-CoV-2 pandemic, we need to better understand its impact in specific
patient groups like those with Cystic Fibrosis (CF). We report on 181 people with CF (32 …

Cognitive conflict and consensus generation in virtual teams during knowledge capture: Comparative effectiveness of techniques

A Chiravuri, D Nazareth… - Journal of Management …, 2011 - Taylor & Francis
D. in management science with a specialization in MIS from the university of … NAZARETH
is an associate professor of MIS at the university of Wisconsin– Milwaukee. he received a Ph.D. …

Input information complexity, perceived time pressure, and information processing in GSS-based work groups: An experimental investigation using a decision schema …

S Paul, DL Nazareth - Decision Support Systems, 2010 - Elsevier
Collaboration technology enhances the ability of work groups to acquire and share large
volumes of information within a short period. The processing of voluminous information is …

Implementing service-oriented architecture in organizations

J Choi, DL Nazareth, HK Jain - Journal of Management Information …, 2010 - Taylor & Francis
D. in Management Information Systems from the University of Wisconsin–Milwaukee. his …
NAZARETH is an associate Professor of MIS at the University of Wisconsin– Milwaukee. he …

Ivacaftor is associated with reduced lung infection by key cystic fibrosis pathogens. A cohort study using national registry data

FJ Frost, DS Nazareth, SC Charman… - Annals of the …, 2019 - atsjournals.org
Rationale: Ivacaftor can greatly improve clinical outcomes in people with cystic fibrosis (CF)
and has been shown to have in vitro antibacterial properties, yet the long-term …

[HTML][HTML] Coming of age in cystic fibrosis–transition from paediatric to adult care

D Nazareth, M Walshaw - Clinical medicine, 2013 - ncbi.nlm.nih.gov
Cystic fibrosis (CF) is the most common multi-system inherited disorder, with a UK population
exceeding 9,000. There have been significant improvements in CF survival over the …

[HTML][HTML] Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis

…, H Makukh, C Martin, L Morrison, D Nazareth… - Journal of Cystic …, 2023 - Elsevier
Cystic fibrosis (CF) has entered the era of variant-specific therapy, tailored to the genetic
variants in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene. CFTR …

Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis

F Frost, M Shaw, D Nazareth - Cochrane Database of …, 2019 - cochranelibrary.com
Background Cystic fibrosis (CF) a life‐limiting inherited disease affecting a number of organs,
but classically associated with chronic lung infection and progressive loss of lung function. …